Cargando…

Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma

BACKGROUND: There is evidence to consider that the tumor microenvironment (TME) composition associates with antitumor immune response, and may predict the outcome of various non-Hodgkin lymphoma subtypes. However, in the case of mantle cell lymphoma (MCL), a rare and aggressive disease, there is lac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assis-Mendonça, Guilherme Rossi, Fattori, André, Rocha, Rafael Malagoli, Lourenço, Gustavo Jacob, Delamain, Márcia Torresan, Nonogaki, Suely, de Lima, Vladmir Cláudio Cordeiro, Colleoni, Gisele Wally Braga, de Souza, Cármino Antonio, Soares, Fernando Augusto, Lima, Carmen Silvia Passos, Vassallo, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919095/ https://www.ncbi.nlm.nih.gov/pubmed/33648463 http://dx.doi.org/10.1186/s12885-021-07891-9

Ejemplares similares

An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course
por: Assis-Mendonça, Guilherme Rossi, et al.
Publicado: (2020)

Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness
por: Assis-Mendonça, Guilherme Rossi, et al.
Publicado: (2020)

Characteristics of follicular and mantle cell lymphoma in Brazil: prognostic impact of clinical parameters and treatment conditions in two hospitals
por: Assis-Mendonça, Guilherme Rossi, et al.
Publicado: (2018)

Involvement of cranial nerves in a patient with secondary central nervous system lymphoma
por: Dantas Azevedo, Roberta, et al.
Publicado: (2016)

Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up
por: PAGNANO, KATIA BORGIA BARBOSA, et al.
Publicado: (2016)

Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome
por: Benites, Bruno Deltreggia, et al.
Publicado: (2013)

Treatment Outcome of Acute Promyelocytic Leukemia with Modified Aida Protocol
por: Pagnano, Kátia B. Barbosa, et al.
Publicado: (2010)

Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center
por: Moura, Ariella Cássia de, et al.
Publicado: (2019)

Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2021)

Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular response
por: Machado, Melissa Pereira, et al.
Publicado: (2011)

Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients
por: de Mendonça, G R A, et al.
Publicado: (2016)

Unusual presentation of a primary low-grade central nervous system lymphoma
por: Cortez, Anita Cassoli, et al.
Publicado: (2022)

Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients
por: Delamain, Marcia Torresan, et al.
Publicado: (2016)

Evaluation of anemia after long-term treatment with imatinib in chronic myeloid leukemia patients in chronic phase
por: Moura, Muriel Silva, et al.
Publicado: (2019)

Pulmonary mantle cell lymphoma: a rare manifestation of an uncommon condition
por: DePew, Zachary S., et al.
Publicado: (2012)

Immunoexpression of claudins 4 and 7 among invasive breast carcinoma subtypes: A large diagnostic study using tissue microarray
por: Logullo, Angela Flávia, et al.
Publicado: (2018)

Inherited lung cancer: a review
por: de Alencar, Viviane Teixeira Loiola, et al.
Publicado: (2020)

Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2015)

May critical molecular cross-talk between indoleamine 2,3-dioxygenase (IDO) and arginase during human aging be targets for immunosenescence control?
por: da Silva, Ismael Dale Cotrim Guerreiro, et al.
Publicado: (2021)

FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells
por: Braga, Walter Moises Tobias, et al.
Publicado: (2014)

Anti‐PD1 versus anti‐PD‐L1 immunotherapy in first‐line therapy for advanced non‐small cell lung cancer: A systematic review and meta‐analysis
por: Brito, Angelo Borsarelli Carvalho, et al.
Publicado: (2021)

Plasma cell leukemia with t(11;14)(q13;q32) simulating lymphoplasmacytic lymphoma – a diagnostic challenge solved by flow cytometry
por: Loureiro, Aleyde Diniz, et al.
Publicado: (2017)

Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas
por: Cunha, Lucas Leite, et al.
Publicado: (2012)

Biochemical phenotyping of multiple myeloma patients at diagnosis reveals a disorder of mitochondrial complexes I and II and a Hartnup-like disturbance as underlying conditions, also influencing different stages of the disease
por: da Silva, Ismael Dale Cotrim Guerreiro, et al.
Publicado: (2020)

VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens
por: Lopes-Aguiar, L, et al.
Publicado: (2017)

Through translational prospective study, the GSTP1 Ile105Val polymorphism emerges as prognostic marker in de novo large B-cell lymphoma patients
por: Delamain, M T, et al.
Publicado: (2017)

The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma
por: Braga, Walter M. T., et al.
Publicado: (2012)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
por: Cardozo, Daniela Maira, et al.
Publicado: (2023)

BAFF receptor antibody for mantle cell lymphoma therapy
por: Zhang, Keman, et al.
Publicado: (2021)

Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy
por: de Alencar, Viviane Teixeira L., et al.
Publicado: (2022)

Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas
por: Duarte, Bruno Kosa Lino, et al.
Publicado: (2011)

Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience
por: Rocha, Talita Máira Bueno da Silveira da, et al.
Publicado: (2017)

Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment
por: Vitiello, Glauco Akelinghton Freire, et al.
Publicado: (2021)

Andean Tectonics and Mantle Dynamics as a Pervasive Influence on Amazonian Ecosystem
por: Bicudo, Tacio Cordeiro, et al.
Publicado: (2019)

A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma
por: Tavares, Monique C., et al.
Publicado: (2021)

A microRNA signature profile in EBV(+) diffuse large B-cell lymphoma of the elderly
por: de Andrade, Tathiana Azevedo, et al.
Publicado: (2014)

Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma
por: Santos, Juliana Carvalho, et al.
Publicado: (2022)

Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma
por: Eugênio, Angela Isabel Pereira, et al.
Publicado: (2017)

Single nucleotide polymorphisms affect miRNA target prediction in bovine
por: de Sousa, Marco Antônio Perpétuo, et al.
Publicado: (2021)

Chylous Ascites due to Mantle Cell Lymphoma
por: Fernandes, Ricardo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ds7squm9l910j9lbgo851kvmub